XBKK
RPH
Market cap82mUSD
Nov 12, Last price
4.92THB
Name
Ratchaphruek Hospital PCL
Chart & Performance
P/E
15.32
P/S
2.35
EPS
0.32
Div Yield, %
6.10%
Shrs. gr., 5y
—
Rev. gr., 5y
6.62%
Revenues
1.13b
-3.05%
Net income
173m
-6.46%
CFO
267m
-26.09%
Dividend
Apr 30, 20250.18 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ratchaphruek Hospital Public Company Limited engages in the hospital business under the Ratchaphruek Hospital name in Thailand. The company provides medical services in the field of internal medicine, such as dermatology, neurology, hematology, pulmonary, rheumatology, gastroenterology, nephrology, diabetes and endocrine, and cardiology; general, urological, and colorectal surgeries; and pediatrics, orthopedics, otorhinolaryngology, ophthalmology, obstetrics and gynecology, check-up, dentistry, anesthesiology, emergency medical, stroke, breast, hearing and balance, rehabilitation, and diagnostic radiology. It also sells medicines and medical supplies. The company was formerly known as Sithan Karnpat Company Limited and changed its name to Ratchaphruek Hospital Public Company Limited in September 2016. Ratchaphruek Hospital Public Company Limited was incorporated in 1993 and is based in Khon Kaen, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||